| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.87B | +41.5% |
| Cost of Revenue | $3.03B | +36.5% |
| Gross Profit | $834.0M | +63.2% |
| R&D Expense | $358.0M | +27.0% |
| SG&A Expense | $362.0M | +23.1% |
| Operating Income | -$287.0M | +25.3% |
| Pre-tax Income | -$244.0M | +11.9% |
| Income Tax | $2.0M | +200.0% |
| Net Income | -$246.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $605.0M | +10.6% |
| Accounts Receivable | $69.0M | -10.4% |
| Inventory | $118.0M | +7.3% |
| Current Assets | $1.57B | +11.6% |
| Total Assets | $1.96B | +11.2% |
| Current Liabilities | $663.0M | +33.7% |
| Total Liabilities | $764.0M | +15.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.0M | +186.5% |
| Investing Cash Flow | -$86.0M | +12.2% |
| Financing Cash Flow | $63.0M | +65.8% |
| +10.5% |
| EPS (Basic) | -$0.46 | +14.8% |
| EPS (Diluted) | -$0.47 | +34.7% |
| Stockholders' Equity |
| $1.19B |
| +8.7% |